CD8A and rheumatoid arthritis: In patients with RA, CD8+ T cells undergo metabolic reprogramming through an mTOR/Myc/HIF-1α-dependent mechanism, shifting their metabolic profile toward aerobic glycolysis, which results in a proinflammatory and active phenotype (106, 107).